Tiziana Life Sciences Ltd (NASDAQ:TLSA) Shares Acquired by Zhang Financial LLC

Zhang Financial LLC increased its stake in Tiziana Life Sciences Ltd (NASDAQ:TLSAFree Report) by 24.2% in the third quarter, Holdings Channel.com reports. The institutional investor owned 69,387 shares of the company’s stock after purchasing an additional 13,500 shares during the quarter. Zhang Financial LLC’s holdings in Tiziana Life Sciences were worth $67,000 as of its most recent SEC filing.

Tiziana Life Sciences Trading Down 1.0 %

TLSA stock opened at $0.92 on Wednesday. Tiziana Life Sciences Ltd has a 1 year low of $0.41 and a 1 year high of $1.74. The stock has a 50-day simple moving average of $1.05 and a 200-day simple moving average of $0.88.

Tiziana Life Sciences Profile

(Free Report)

Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases.

Featured Articles

Want to see what other hedge funds are holding TLSA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tiziana Life Sciences Ltd (NASDAQ:TLSAFree Report).

Receive News & Ratings for Tiziana Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tiziana Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.